Medical Design Technology -
14 Feb 2018 21:35
News A new study has shown that a cancer-killing ('oncolytic') virus currently in clinical trials may function as a cancer vaccine -- in addition to killing some cancer cells directly, the virus alerts the immune system to the presence of ... Contributed Author: University of California - San Francisco Topics: Oncology
Share this Article